Citation Impact
Citing Papers
Place of Cabergoline in Acromegaly: A Meta-Analysis
2011
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
2006 StandoutNobel
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Overexpression of protein kinase C-alpha and -beta isozymes by stromal dendritic cells in basal and squamous cell carcinoma.
1997
RNA-seq Profiling of Small Numbers of Drosophila Neurons
2014 StandoutNobel
Acromegaly
2006 Standout
17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production
2001
Prolactin-producing pituitary tumor: resistance to dopamine agonist therapy
1995
Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify Different Tumoral Phenotypes1
2000
Physiology of BDNF: focus on hypothalamic function
2004
Dopamine Resistance of Prolactinomas
2003
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
2000 StandoutNobel
Nongenomic Stimulation of Nitric Oxide Release by Estrogen Is Mediated by Estrogen Receptor α Localized in Caveolae
1999
Nerve Growth Factor in Pituitary Development and Pituitary Tumors
1998
Cushing's syndrome
2015 Standout
Molecular defects in the pathogenesis of pituitary tumours
2003
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Effect of pegylation on pharmaceuticals
2003 Standout
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery
2002
Multiple coupling of neurohormone receptors with cyclic AMP and inositol phosphate production in anterior pituitary cells
1987
The adolescent brain and age-related behavioral manifestations
2000 Standout
Selective Expression of Estrogen Receptor α and β Isoforms in Human Pituitary Tumors1
1998
Alzheimer's disease: amyloid plaques in the cerebellum
1989
Acromegaly
1990
Chronic prolactin, gonadal and thyroid hormone treatments in vivo alter levels of TRH and muscarinic receptors in male and female rat tissues
1988
Neuropathological stageing of Alzheimer-related changes
1991 Standout
Regulation of Interneuron Function in the C. elegans Thermoregulatory Pathway by the ttx-3 LIM Homeobox Gene
1997 StandoutNobel
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
1994
MEDICAL TREATMENT OF PROLACTINOMAS
1999
Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment
1997
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene.
1996
High interstitial fluid pressure — an obstacle in cancer therapy
2004 Standout
The Drosophila islet Gene Governs Axon Pathfinding and Neurotransmitter Identity
1997
Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors
2003
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors
2004
Bioactive peptides in anterior pituitary cells
1994
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
2006 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Effect of glucocorticoids on the paradoxical growth hormone response to thyrotropin-releasing hormone in patients with acromegaly
1995
Hyperprolactinemia and Prolactinomas
2008
Growth hormone response to thyrotropin releasing hormone and placebo in a group of insulin dependent diabetic patients
1989
Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*
1991 Standout
Presence of Ghrelin in Normal and Adenomatous Human Pituitary
2001
Tissue‐specific developmental requirements of Drosophila tyrosine hydroxylase isoforms
2003
Intercellular interactions in the anterior pituitary
1994
Production and Actions of Estrogens
2002 Standout
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Cushing's syndrome
2006 Standout
Pituitary Lactotroph Hyperplasia and Chronic Hyperprolactinemia in Dopamine D2 Receptor-Deficient Mice
1997
Intercellular Communication Within the Anterior Pituitary Influencing the Secretion of Hypophysial Hormones*
1992
Ghrelin: Structure and Function
2005 Standout
G protein modulation by estrogens
1991
Estrogen Actions in the Central Nervous System1
1999 Standout
Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery
1998
Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
1997
Breast cancer cell invasiveness: Correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells
1998
Sex Differences in Alcohol Preference and Drinking Patterns Emerge during the Early Postpubertal Period in Sprague‐Dawley Rats
1996
Redox Control of Protein Kinase C: Cell- and Disease-Specific Aspects
2010
Activity of the Caenorhabditis elegans UNC-86 POU transcription factor modulates olfactory sensitivity
2003 StandoutNobel
The Complex Role of Estrogens in Inflammation
2007 Standout
The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens.
1995
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Pituitary Lactotroph Adenomas Develop after Prolonged Lactotroph Hyperplasia in Dopamine D2 Receptor-Deficient Mice1
1999
Effect of single or repeated estrogen administration on tuberoinfundibular GABA neurons and anterior pituitary GABA receptors: Biochemical and functional studies
1985
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone
1983
Treatment of Acromegaly with Dopamine Agonists
1992
Pituitary sex steroid receptors: Localization and function
1997
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
1996
Pituitary tumors and pregnancy
1978
Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors
2006
Regulation of touch receptor differentiation by the Caenorhabditis elegans mec-3 and unc-86 genes
1998 StandoutNobel
Impact of circulating estradiol on melatonin binding sites in discrete areas of the female rat brain
1987
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Coordinated Transcriptional Regulation of theunc-25Glutamic Acid Decarboxylase and theunc-47GABA Vesicular Transporter by theCaenorhabditis elegansUNC-30 Homeodomain Protein
1999 StandoutNobel
The Expression of the Growth Hormone Secretagogue Receptor Ligand Ghrelin in Normal and Abnormal Human Pituitary and Other Neuroendocrine Tumors1
2001
Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients
2008
Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients
1999
Binding of 1α,25‐dihydroxyvitamin D 3 to annexin II: Effect of vitamin D metabolites and calcium
2000
The Caenorhabditis elegans lim-6 LIM homeobox gene regulates neurite outgrowth and function of particular GABAergic neurons
1999 StandoutNobel
Mechanisms of Estrogen Action
2001 Standout
Nongenomic Steroid Action: Controversies, Questions, and Answers
2003
Advances in the Treatment of Prolactinomas
2006
Estrogen Receptor-α Detected on the Plasma Membrane of Aldehyde-Fixed GH3/B6/F10 Rat Pituitary Tumor Cells by Enzyme-Linked Immunocytochemistry*
1999
Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment
1997
TheC. elegansPOU-domain transcription factor UNC-86 regulates thetph-1tryptophan hydroxylase gene and neurite outgrowth in specific serotonergic neurons
2002 StandoutNobel
Induction of classical lactotropes by epidermal growth factor in rat pituitary cell cultures.
1995
Cell signaling and estrogens in female rat osteoblasts: A possible involvement of unconventional nonnuclear receptors
1993
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas.
1994
Successful treatment of resistant acromegaly with a growth hormone receptor antagonist
2001
Steroid Sex Hormones and Macrophage Function: Regulation of Chemiluminescence and Phagocytosis
1996
17-β-Estradiol-Dependent Regulation of Somatostatin Receptor Subtype Expression in the 7315b Prolactin Secreting Rat Pituitary Tumor in Vitro and in Vivo*
1997
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Thyrotropin-Releasing Hormone Gene Expression in the Anterior Pituitary. IV. Evidence for Paracrine and Autocrine Regulation
1998
Novel insights into how purines regulate pituitary cell function
2003
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group.
1995
The Molecular Pathogenesis of Corticotroph Tumors
1999
Growth hormone secretion in recently operated acromegalic patients.
1994
Annexins: From Structure to Function
2002 Standout
SPECIFIC, NONGENOMIC ACTIONS OF STEROID HORMONES
1997
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Control of Neural Development and Function in a Thermoregulatory Network by the LIM Homeobox Genelin-11
1998 StandoutNobel
Macroprolactinoma Shrinkage during Cabergoline Treatment Is Greater in Naive Patients Than in Patients Pretreated with Other Dopamine Agonists: A Prospective Study in 110 Patients1
2000
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas.
2010
Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.
1994
Thyrotropin-releasing hormone (TRH) gene expression in the anterior pituitary. I. Presence of pro-TRH messenger ribonucleic acid and pro-TRH-derived peptide in a subpopulation of somatotrophs.
1994
Angiogenesis in Endocrine Tumors
2003
The Cytogenesis and Pathogenesis of Pituitary Adenomas*
1998
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
2002 Standout
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors.
1994
Expression of Somatostatin Receptor (SSTR) Subtypes in Pituitary Adenomas: Quantitative Analysis of SSTR2 mRNA by Reverse Transcription‐Polymerase Chain Reaction
1996
Dopamine Receptors on Intact Anterior Pituitary Cells in Culture: Functional Association with the Inhibition of Prolactin and Thyrotropin*
1983
Dopamine Receptors: From Structure to Function
1998 Standout
Neuroendocrine Control of Growth Hormone Secretion
1999
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Membrane estrogen receptors identified by multiple antibody labeling and impeded‐ligand binding
1995
Works of F Peillon being referenced
Evidence of Pre-Prosomatostatin mRNA in Human Normal and Tumoral Anterior Pituitary Gland
1989
Normal and Adenomatous Human Pituitaries Secrete Thyrotropin-Releasing HormoneIn vitro: Modulation by Dopamine, Haloperidol, and Somatostatin
1990
Immunoreactive thyroliberin (TRH) precursor forms in human hypothalamus and anterior pituitary tissues
1992
Resistance to Bromocriptine in Prolactinomas
1989
Altered Balance between Thyrotropin-Releasing Hormone and Dopamine in Prolactinomas and Other Pituitary Tumors Compared to Normal Pituitaries
1989
Growth hormone-releasing hormone and somatostatin in normal and tumoral human pituitaries
1991
Normal and Growth Hormone (GH)-Secreting Adenomatous Human Pituitaries Release Somatostatin and GH-Releasing Hormone
1989
Neuropeptides of Anterior Pituitary Origin
1991
Multiple tyrosine hydroxylase transcripts and immunoreactive forms in the rat: Differential expression in the anterior pituitary and adrenal gland
1995
Alterations in central neurotransmitter receptor binding sites following estradiol implantation in female rats
1983
Pituitary Enlargement with Suprasellar Extension in Functional Hyperprolactinemia due to Lactotroph Hyperplasia: A Pseudotumoral Disease
1991
Effect of Oestradiol on Dopamine Receptors and Protein Kinase C Activity in the Rat Pituitary: Binding of Oestradiol to Pituitary Membranes
2007
Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas
1994
Immunocytochemistry of four mixed pituitary adenomas and intrasellar gangliocytomas associated with different clinical syndromes: Acromegaly, amenorrhea-galactorrhea, Cushing's disease and isolated tumoral syndrome
1989
Apparently Silent Somatotroph Adenomas
1991
Specific alterations of the basement membrane and stroma antigens in Human pituitary tumours in comparison with the normal anterior pituitary. An immunocytochemical study
1992
Evidence of Thyrotropin-Releasing Hormone (TRH) and TRH-Binding Sites in Human Nonsecreting Pituitary Adenomas
1987
In Vitro Effect of Dopamine and L-Dopa on Prolactin and Growth Hormone Release from Human Pituitary Adenomas*
1979
Biochemical and functional alterations of central GABA receptors during chronic estradiol treatment
1983
Modifications of the High and Low Affinity Pituitary Domperidone-Binding Sites in Chronic Estrogenized Rats*
1983
Evidence for a Specific Estradiol Binding Site on Rat Pituitary Membranes
1986
Dopaminergic Receptors in Human Prolactin-Secreting Adenomas: A Quantitative Study*
1980
Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
1993
Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C.
1993
Epidermal Growth Factor-Binding Sites, Present in Normal Human and Rat Pituitaries, Are Absent in Human Pituitary Adenomas*
1987
[Paracrine regulation of anterior pituitary hormones by neuropeptides].
1997
In Vitroandin VivoAntagonistic Regulation by Estradiol and Progesterone of the Rat Pituitary Domperidone Binding Sites: Correlation with Ovarian Steroid Regulation of the Dopaminergic Inhibition of Prolactin Secretionin Vitro*
1985
[Proceedings: Prolactin adenoma revealed by gemellary? pregnancy after clomiphen therapy. Hypophysectomy during 5 th month of pregnancy (author's transl)].
1976
Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumor size as predicting factors.
1980
Presence and characterization of the somatostatin precursor in normal human pituitaries and in growth hormone secreting adenomas.
1993
Somatostatin and regulation of prolactin secretion
1986
Interaction between Somatostatin and TRH on Growth Hormone Secretion in Perifused Human Growth Hormone Tumor Cells
1985
[Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].
1979
Evidence of Dopamine Receptors in Human Growth Hormone (GH)-Secreting Adenomas with Concomitant Study of Dopamine Inhibition of GH Secretion in a Perifusion System*
1982
Surgical Treatment of Prolactinomas
1985
Somatostatin Receptors in Human Growth Hormone and Prolactin- Secreting Pituitary Adenomas
1985
Evidence of gonadotropin-releasing hormone mRNA in the rat anterior pituitary.
1992
[Neurohormones coming from the normal and tumoral human anterior pituitary. Secretion and regulation in vitro].
1989
Estrogen Receptors in Human Pituitary Adenomas*
1980
Correlative Studies between the Presence of Thyrotropin-Releasing Hormone (TRH) Receptors and the In Vitro Stimulation of Growth-Hormone (GH) Secretion in Human GH-Secreting Adenomas
1985
[In vitro secretion of somatostatin (SRIH) by human adenomatous somatotropic cells. Relation with somatotropic hormone (GH) release and modulation by thyroliberin (TRH)].
1988